Sofosbuvir Intermediate CAS 21382-82-1 Purity ≥98.0% (HPLC)
Pasokan Komersial Sofosbuvir sareng Panganteur Patali:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[étoksikarbonil]étildéna)fosforan CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanin 1-métilétil éster CAS: 1334513-02-8
Ngaran | triphenyl(1-[étoksikarbonil]étildéna)fosforan |
sinonim | 2-(triphenyl-phosphanylidene)-propionic acid étil éster |
Nomer CAS | 21382-82-1 |
Nomer CAT | RF-PI179 |
Status saham | Dina Stok, Skala Produksi Nepi ka Ton |
Formula Molekul | C23H23O2P |
Beurat Molekul | 362.41 |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Bubuk konéng |
Kamurnian / Métode Analisis | ≥98,0% (HPLC) |
Leungitna dina Drying | ≤1,0% (60 ℃, 2h) |
Jumlah PH3P+PH3PO | ≤2.0% (HPLC) |
Zat Patali Unspecified | ≤0,5% (HPLC) |
Standar tés | Standar Perusahaan |
Pamakéan | Panganteur Sofosbuvir (CAS: 1190307-88-0) |
Bungkusan: Botol, kantong Aluminium foil, kardus drum, 25kg / Drum, atawa nurutkeun sarat customer urang.
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya, Uap jeung infestation hama.
Produsén kalawan Purity High sarta Quality Stabil
Sofosbuvir Pasokan Komérsial (CAS: 1190307-88-0) sareng Perantara Patali:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[étoksikarbonil]étildéna)fosforan CAS: 21382-82-1
L-Alanine Isopropil Éster Hydrochloride CAS: 62062-65-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanin 1-métilétil éster CAS: 1334513-02-8
Sofosbuvir mangrupikeun ubar anu dianggo pikeun pengobatan hépatitis C. Disarankeun dianggo digabungkeun sareng obat-obatan sanés (sapertos velpatasvir) pikeun pengobatan lini kahiji pikeun genotip HCV 1, 2, 3, 4, 5, sareng 6. Éta dikuatkeun ku akting salaku inhibitor analog nukléotida, mampuh sacara khusus ngahambat HCV NS5B (protein non-struktural 5B) RNA-dependent RNA polymerase.